Navigation Links
Bacteria In Yogurt Can Combat HIV Infection

Conquering the AIDS virus continues to be a challenging task to members of the scientific community. Thanks to the perseverant efforts of the Brown University researchers who have genetically manipulated bacteria present in yoghurt to release an anti-HIV drug. // The results of this research can be found in the Journal of Acquired Immune Deficiency Syndrome.

The research has promised a new ray of hope to curbing a disease that has been haunting the whole world. Although successful results have only been obtained in laboratory conditions, the researchers are optimistic that it could eventually pave way for the development of a cost-effective strategy for effective delivery of anti-retroviral drugs.

The research team, headed by Bharat Ramratnam, a specialist in HIV/AIDS have sucessfully altered the genetic constitution of Lactobacillus lactis to enable release of cyanovirin. This drug has already been found to confer protection against HIV infection in monkeys and human cells (in vitro culture).

It is further hoped to initiate human clinical trials of the drug before next year. Until then, the conventional methods of HIV prevention such as safe sex and use of a condom would hold good.


'"/>




Page: 1

Related medicine news :

1. Bacterial discovery may help CF patients
2. Cure for Bacterial Meningitis
3. Before Weight Loss Surgery One Should Get Tested for Bacteria
4. Molecule That Aids Bacterial Infections Identified
5. Moms Stomach Bacteria Can Cause Leukaemia In Children
6. Bacteria Evolve Armamentarium Against Antibiotics By ‘Stealing’ Gens
7. Bacterial Photographs Created By Student Scientists!
8. Bacterial infestation in food very critical!
9. Tooth Decay Bacteria Unaffected By Altered Biochemical Pathway
10. Beneficial Symbiotic Relationship Between Ants And Bacteria.
11. Tamiflu substrate produced from Bioengineered Bacteria
Post Your Comments:
(Date:9/5/2008)... helps reverse disease resistance to anti-hormonal...News) -- The drug sorafenib may help "re-sensitize...ugs, Georgetown University Medical Center researc...gesterone-receptor positive (ER or PR positive) me...edicines, such as aromatase inhibitors, to keep th...
(Date:9/5/2008)...York Fashion Week,s Annual Destination to Feature ...w York (PRWEB) September 5, 2008 -- http://www.a..._ American Laser], the largest provider of laser h...es in the U.S., announces sponsorship of the STYLE...from Sept. 7-10, serves as the alternative Fashion...
(Date:9/4/2008)...ontrol study, the presence of measles virus RNA wa...sturbances than in children with only GI disturban...e unrelated to MMR vaccine timing. Study findings...ence on September 4 ( http://dx.plos.org/10.1371/...ation of measles vaccines in 1963, three to four m...
(Date:9/4/2008)...ng about fungal infection risk , , THUR...uthorities have asked the manufacturers of four wi...y warnings on the risk of developing opportunistic..., Enbrel and Remicade, belong to a class of medica...s (TNF-alpha blockers), which suppress the immune ...
Breaking Medicine News(10 mins):Health News:Drug Re-Sensitizes Breast Tumors to Treatment 2Health News:American Laser Centers Sponsors STYLE360 to Share the Skinny on Body Shaping 2Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 2Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 3Health News:FDA Demands Tougher Warnings on Immunosuppressive Drugs 2Health News:FDA Demands Tougher Warnings on Immunosuppressive Drugs 3
...joying the sun in its totality, without the sunscr...in UK skin cancer figures are close to 65,400as pe...ople annually contract a deadly malignant melanoma... every year. Underlying the importance of sunscre...
...nd that the body is capable of manufacturing its o...ary tract infection//. It was thought that the ver...hich prevented bacteria from forming in the membra...t of Microbiology, Tumour and Cell Biology at the ...
...o Hospitals has registered the second highest succ...r cent of such procedures done //by it are success...d here today. Delivering an address at a Nurses D...ital that had the highest success rate charged 50,...
...3.66 crore has been sanctioned for providing nutri...mmu and Kashmir's Doda district //during the curre...said today. A total of 1,010 Aanganwari centres ar...3 more are being set up during the current fiscal,...
Other Medicine News:
(Date:9/4/2008)...letin for Obstetrician-Gynecologists States UFE Me...Minimally Invasive Interventional,Radiology Treatm...ne,Fibroids, FAIRFAX, Va., Sept. 4 /PRNewswire-US...gy, a national organization of nearly 4,500 doctor...cated to improving health,care through minimally i...
(Date:9/4/2008)...eeks to Enroll 750 Women at More Than 100 Sites in... -- QuatRx Pharmaceuticals, a,privately-held bioph...mmercialization of compounds to treat endocrine, m...nced that it has initiated a second,Phase 3 clinic...ompany,s,estrogen-free oral therapy in development...
(Date:9/4/2008)...ted Survival Data for Ipilimumab to be Presented, ...- Medarex, Inc.,(Nasdaq: MEDX ) announced today t...estigational anti-CTLA-4 antibody, in melanoma are...he 33rd Congress of the European Society,for Medic...8 in Stockholm.,Many of the following abstracts wi...
(Date:9/4/2008)...mizing Patient Identification for Targeted Therapi...ed Treatment HUNTINGTON BEACH, Calif., and AMST...a, a world leader in molecular cancer diagnostics,...ew diagnostic test that,allows physicians to quant...the estrogen receptor (ER), progesterone receptor ...
Breaking Medicine Technology:Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 3QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3Agendia Launches TargetPrint(R) for Breast Cancer Patients 2CV Therapeutics To Announce 2007 Third Quarter Financial Results on Tuesday November 6 2007 1224 1CV Therapeutics To Announce 2007 Third Quarter Financial Results on Tuesday November 6 2007 1224 2Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor 1220 1Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor 1220 2AACR BCRF award inaugural grants in translational breast cancer research 772 1AACR BCRF award inaugural grants in translational breast cancer research 772 2AACR BCRF award inaugural grants in translational breast cancer research 772 3Chlamy genome holds clues for renewable energy the environment and human health 768 1Chlamy genome holds clues for renewable energy the environment and human health 768 2
Used for complex diagnostic and interventional procedures.
The Emerald Guidewire is intended for percutaneous introduction of catheters.
St. Jude Medical offers a complete line of diagnostic guidewires for use with percutaneous catheter introducers to aid the insertion of intravascular catheters. Our diagnostic guidewires are availabl
Used to negotiate tortuous vessels.
Medicine Products: